Rapid performance increase of RSA drugs requiring system modification

While the industry has had continuous issues about effectiveness of the Risk Sharing Agreement(RSA) System, drugs agreed to the system were observed to be increased in sales.

In an objective perspective about the aggregation, accessibility of pharmaceutical products has actually been improved by the system. A number of managers concerned to the pharmaceutical industry have started to have posi...